Prostate Cancer Research
Overview
Prostate Cancer Research is a UK-based charity founded in 1989 that funds medical research and invests in early-stage companies to develop new treatments and diagnostics for prostate cancer.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lucida Medical | Mar 2021 | Seed | Lead |
| Nanovery | Apr 2023 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Prostate Cancer Research based?
Prostate Cancer Research is headquartered in London, United Kingdom.
When was Prostate Cancer Research founded?
Prostate Cancer Research was founded in 1989.
How many portfolio companies does Prostate Cancer Research have?
Prostate Cancer Research has 2 portfolio companies in Caplight's dataset.
What are some companies in Prostate Cancer Research's portfolio?
Portfolio companies visible on Caplight include Lucida Medical, Nanovery.
What was Prostate Cancer Research's most recent investment shown here?
Prostate Cancer Research's most recent investment in this portfolio sample was in Nanovery in 2023.
What sectors does Prostate Cancer Research focus on?
Prostate Cancer Research focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Prostate Cancer Research focus on?
Prostate Cancer Research typically invests at the Early stage.